Cost-Effectiveness Analysis of Ofatumumab versus Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A 10-Year Markov Model

Ziyad Saeed Almalki, Mashael Mafleh Alshammari, Saja H. Almazrou, Ohud Abd Alhadi Alqahtani, Maryam Riyadh Alkhayat, Shahad Fahad Alnemari, Haya Showky Mukhemair, Sara Mohamaad Alkredeas, Abdulrahman A. Alsuhibani, Bushra Yousif Asiri, Tala Nouraldin Alalawi, Abdullah K. Alahmari, Fahad Obaid Alotaibi

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Cost-Effectiveness Analysis of Ofatumumab versus Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A 10-Year Markov Model'. Together they form a unique fingerprint.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology